DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Olanzapine
Olanzapine
Current P SYCHIATRY
Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice
Olanzapine-Induced Acute Pancreatitis and New Diabetes Mellitus
Olanzapine and Clozapine Increase the Gabaergic Neuroactive Steroid Allopregnanolone in Rodents
List Item Olanzapine Teva
ARISTADA INITIO® Prescribing Information
Currently Prescribed Psychotropic Medications
Augmentation of Olanzapine by Fluphenazine Decanoate in Poorly Responsive Schizophrenia Saeed Shoja Shafti 1
Antidepressant Medication Management HEDIS Tip Sheet
Olanzapine Compared to Quetiapine in Adolescents with a First Psychotic
Drug-Induced Parkinsonism
High-Risk Medications in the Elderly
PTSD Nightmares: Prazosin and Atypical Antipsychotics
TOX.LC.3499 Rev 07, Effective 2015-08-12 to Present
Atypical Injectable Antipsychotics for Schizophrenia Or Bipolar Disorder: a Review of Clinical Effectiveness And
Long-Acting Injectable Antipsychotics: What to Do About Missed Doses Use a Stepwise Approach Based on the Unique Properties of the Specific Medication
The Continuum Hypothesis
Management of Acutely Disturbed Behaviour
Top View
Recommendations for Lab Monitoring of Atypical Antipsychotics
Aripiprazole Lauroxil Long-Acting Injectable: the Latest Addition to Second-Generation Long-Acting Agents Arpit Aggarwal 1, Ganesh Gopalakrishna 1, John Lauriello 1
Long-Acting Injectable Antipsychotics: Haloperidol and Fluphenazine
Olanzapine Reduces Craving for Alcohol: a DRD4 VNTR Polymorphism by Pharmacotherapy Interaction
Prescribing Information
Olanzapine Orally Disintegrating Tablets) Is Intended for Oral Administration Only
Olanzapine Plasma Concentration, Average Daily Dose, And
Potentially Harmful Drugs in the Elderly: Beers List and More
Commonly Prescribed Psychotropic Medications
Atypical Antipsychotic As Add-On Therapy in Obsessive Compulsive Disorder
Intramuscular Preparations of Antipsychotics Uses and Relevance in Clinical Practice
FDA Warns About Serious Risks and Death When Combining Opioid Pain Or Cough Medicines with Benzodiazepines; Requires Its Strongest Warning
Eruptive Xanthomas Associated with Olanzapine Use
Olanzapine-Related Repetitive Focal Seizures with Lingual Dystonia
ZYPREXA (Olanzapine)
Pharmacological Treatments for Patients with Treatment-Resistant Depression
The Rapid Tranquillisation Policy (Including the Use of Oral PRN Medication) (Replaces Policy No
Patients with a History of Falls and Receiving Tricyclic Antidepressants, Antipsychotics, Or Sleep Agents